Can-Fite Biopharma (CANF) Q1 2026 Earnings

Mar 26Confirmed
Q4 2024
Q2 2025
Q3 2025
Q1 2026
-2.99
-1.99
-0.99
0

Details

Expected EPS
0
Actual EPS
-2.985
Surprise EPS
-2.99
Surprise Percent
N/A

Description

⁨Can-Fite Biopharma⁩ (⁦CANF⁩) has reported earnings of ⁦-2.985⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts